×
0 -0.00031569716457165 0.000292312189418241 0 -0.0020461853259281 -0.00496930722011113 -0.00555393159894761 -0.00555393159894761
Stockreport

Is Teva Pharma's Restructuring Plan Actually 'More Reasonable'? [Investor's Business Daily]

DR REDDY LABS (RDY)  More Company Research Source: Investors Business Daily
US:NYSE Investor Relations: drreddys.com/investors
PDF Technology Related news 12:32 PM ET Regeneron should benefit after Novartis and Roche presented data for competitors to blockbuster eye drug Eylea. IBD Rating Upgrades: Momenta Pharmaceuticals Shows Improved Technical Strength Biotech Investors Flee In Droves As Market Correction Rocks The Group Regeneron Dips In Sympathy With Biotechs Despite Quarterly Beat Teva Beats Quarterly Views But Dives On Weak 2018 Guidance GlaxoSmithKline Slips On 2018 Guidance As Generic Advair Looms Teva Pharmaceutical Reaches 80-Plus Relative Strength Rating Benchmark Gilead Beats Quarterly Views, But Topples On Soft 2018 Guidance These Biotech Stocks Each Dived More Than 20% — Is The Sell-Off Overdone? Teva Pharmaceutical ( TEVA ) jumped Monday after grabbing an upgrade and a price target boost on its 2018 restructuring plan which looks "more reasonable," one analyst said. X Credit Suisse analyst Vamil Divan upgraded Teva to an outperform rating from n [Read more]

IMPACT SNAPSHOT EVENT TIME: RDY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS